Preliminary experiments reveal conolidine may well inhibit distinct ion channels, cutting down neuronal excitability and limiting soreness indicators. This mechanism is especially appropriate in neuropathic soreness, wherever abnormal signaling causes persistent irritation. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways